Selective T-Cell Depletion to Reduce GVHD (Patients) Receiving Stem Cell Tx to Treat Leukemia, Lymphoma or MDS

Clinical trial NCT00025662 · COMPLETED

Trial details

NCT number: NCT00025662
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Graft vs Host Disease Myelodysplastic Syndromes Leukemia Leukemia, Myeloid Leukemia, Myelomonocytic, Chronic Leukemia, Lymphocytic Lymphoma Lymphoma, Mantle-cell Lymphoma, Non-Hodgkin Hodgkin Disease

Start date: 2001-05-01
Primary completion: 2008-02-01
Enrollment: 23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.